Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | Building B15 And 25 Coyol Free Zone ALAJUELA VG1110 |
Tel: | 1-415-8281044 |
Website: | https://establishmentlabs.com |
IR: | See website |
Key People | ||
Juan Jose Chacon Quiros Chief Executive Officer, Director | Rajbir S. Denhoy Chief Financial Officer | Roberto De Mezerville Chief Technology Officer | S. Ross Mansbach Chief Compliance Officer, General Counsel |
Business Overview |
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. |
Financial Overview |
For the fiscal year ended 31 December 2023, Establishment Labs Holdings Inc revenues increased 2% to $165.2M. Net loss increased 4% to $78.5M. Revenues reflect Europe segment increase of 65% to $80.2M, Other segment increase from $994K to $2.2M. Higher net loss reflects Sales, general and administrative increase of 16% to $133.5M (expense), Research and development increase of 34% to $24.2M (expense). |
Employees: | 908 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $1,581M as of Dec 31, 2023 |
Annual revenue (TTM): | $165.15M as of Dec 31, 2023 |
EBITDA (TTM): | -$61.03M as of Dec 31, 2023 |
Net annual income (TTM): | -$78.50M as of Dec 31, 2023 |
Free cash flow (TTM): | -$113.06M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $148.70M as of Dec 31, 2023 |
Shares outstanding: | 27,459,680 as of Apr 4, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |